Kinoshita O, Masuda I, Suzuki M, Tsushima M, Nishioeda Y, Matsuyama T, Kojima H, Harano Y
Division of Atherosclerosis, Metabolism and Clinical Nutrition, National Cardiovascular Center, Osaka, Japan.
Endocrinol Jpn. 1991 Oct;38(5):465-70. doi: 10.1507/endocrj1954.38.465.
We have seen a case of "diabetic non-ketotic hyperosmolar coma" with ketosis. An 84-year-old man was brought into the hospital in a deeply comatous and dehydrated state. The initial blood glucose level was 1252 mg/dl with plasma osmolarity of 435 mOsm/l, but no ketonuria was detected by the nitroprusside method (Ketostix). However, the plasma 3-hydroxybutyrate (3-OHBA) level was 5 mM in a newly developed bedside film test. The serum ketone bodies were later found to be 5.56 and 0.82 mmol/l for 3-OHBA and acetoacetate (AcAc), respectively. A marked increase in glucagon, cortisol and ADH with renal dysfunction (creatinine 5.0 mg/dl) were noted. An abnormal electrocardiogram, occular convergence and chorea like movement disappeared after correction of metabolic disturbances. The moderate level of IRI (14 microU/ml) on admission and a good response to glucagon 2 months after admission also indicate that the present case is a typical hyperosmolar non-ketotic coma. Because of a preferential increase in 3-OHBA, ketonuria seemed to be absent in the regular nitroprusside test. Marked dehydration is thought to cause renal dysfunction, and the increase in ADH may have helped to prevent further aggravation of ketoacidosis. We propose to change the term hyperosmolar non-ketotic coma (HNC) to diabetic hyperosmolar coma (DHC), because sometimes patients with hyperosmolar non-ketotic diabetic coma are ketotic, as seen in the present case. Determination of 3-OHBA or individual ketone bodies in blood is important and essential for the differential diagnosis of diabetic coma. The diagnosis of either ketoacidotic or hyperosmolar coma should be made depending on the major expression of ketoacidosis or hyperglycemic hyperosmolarity.
我们遇到了一例伴有酮症的“糖尿病非酮症高渗性昏迷”。一名84岁男性被送入医院时处于深度昏迷和脱水状态。初始血糖水平为1252mg/dl,血浆渗透压为435mOsm/l,但用硝普盐法(酮体试纸)未检测到酮尿。然而,在新开发的床边薄膜试验中,血浆3-羟基丁酸(3-OHBA)水平为5mM。后来发现血清酮体中3-OHBA和乙酰乙酸(AcAc)分别为5.56和0.82mmol/l。注意到胰高血糖素、皮质醇和抗利尿激素显著增加,同时存在肾功能不全(肌酐5.0mg/dl)。代谢紊乱纠正后,异常心电图、眼球会聚和舞蹈样动作消失。入院时胰岛素释放指数(IRI)水平中等(14微单位/ml),入院2个月后对胰高血糖素反应良好,也表明本病例为典型的高渗性非酮症昏迷。由于3-OHBA优先增加,常规硝普盐试验中似乎没有酮尿。严重脱水被认为会导致肾功能不全,抗利尿激素的增加可能有助于防止酮症酸中毒进一步加重。我们建议将高渗性非酮症昏迷(HNC)一词改为糖尿病高渗性昏迷(DHC),因为有时高渗性非酮症糖尿病昏迷患者会出现酮症,如本病例所示。测定血液中的3-OHBA或个体酮体对于糖尿病昏迷的鉴别诊断很重要且必不可少。应根据酮症酸中毒或高血糖高渗状态的主要表现来诊断酮症酸中毒或高渗性昏迷。